{"id":"W1965568377","doi":"10.1038/bjc.2012.272","title":"PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Ministero dello Sviluppo Economico; Gertrude von Meissner-Stiftung; Ontario Ministry of Economic Development and Innovation; Canadian Institutes of Health Research; Genome Canada; Wellcome Trust; GlaxoSmithKline; Pfizer; Eli Lilly and Company","keywords":"PIM1; Cancer research; Diffuse large B-cell lymphoma; Biology; Kinase; Lymphoma; Tissue microarray; Signal transduction; Cell growth; Cell biology; Phosphorylation; Immunohistochemistry; Immunology; Serine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002470543,0.000257142,0.0002801031,0.0003336504,0.0001493917,0.0004305784,0.0001476608,0.0001828929,0.001098634],"category_scores_gemma":[0.0002216141,0.0001059262,0.0001340704,0.0002784315,0.0002124121,0.0002455488,0.0001643372,0.0005030353,0.0003247472],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004129258,"about_ca_system_score_gemma":0.0001666688,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001988497,"about_ca_topic_score_gemma":0.0004421382,"domain_scores_codex":[0.9999224,0.00002090421,0.000004850491,0.00001141126,0.00002291289,0.00001748629],"domain_scores_gemma":[0.9999082,0.00002769282,0.00003168494,0.000005574811,0.00001107603,0.0000156699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002343723,0.0002560288,0.0206063,0.001093378,0.00006060015,0.001229453,0.0001318977,0.001309719,0.750721,0.001344563,0.001817284,0.2190861],"study_design_scores_gemma":[0.0006683646,0.005466967,0.1888742,0.000225249,0.0004213619,0.01699425,0.0003740503,0.006494843,0.6930431,0.001912639,0.08547872,0.00004615759],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8869223,0.1005171,0.003460939,0.0009539522,0.00005216537,0.00007590582,0.0003996225,0.0001409774,0.007476939],"genre_scores_gemma":[0.9764236,0.01915489,0.002656558,0.0001290424,0.00008139243,0.00003711737,0.0004895225,0.00001199057,0.001016072],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001098634,"threshold_uncertainty_score":0.003675282,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01018648345234164,"score_gpt":0.2936566803929901,"score_spread":0.2834701969406485,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}